Clinical Trials Browser

Phase 2 × INDUSTRY × Metastatic Castration-resistant Prostate Cancer (mCRPC) × Clear all

NCT06241846 2025-08-27

A Phase II Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With mCRPC

Phase 2 Recruiting

Metastatic Castration-resistant Prostate Cancer (mCRPC)